The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020)
M Egi, H Ogura, T Yatabe, K Atagi, S Inoue, T Iba… - Journal of intensive …, 2021 - Springer
Abstract The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic
Shock 2020 (J-SSCG 2020), a Japanese-specific set of clinical practice guidelines for sepsis …
Shock 2020 (J-SSCG 2020), a Japanese-specific set of clinical practice guidelines for sepsis …
Pharmacokinetics–pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients
RP Veiga, JA Paiva - Critical Care, 2018 - Springer
Antimicrobials are among the most important and commonly prescribed drugs in the
management of critically ill patients and beta-lactams are the most common antibiotic class …
management of critically ill patients and beta-lactams are the most common antibiotic class …
Meropenem population pharmacokinetics in critically ill patients with septic shock and continuous renal replacement therapy: influence of residual diuresis on dose …
M Ulldemolins, D Soy, M Llaurado-Serra… - Antimicrobial agents …, 2015 - Am Soc Microbiol
Meropenem dosing in critically ill patients with septic shock and continuous renal
replacement therapy (CRRT) is complex, with the recommended maintenance doses being …
replacement therapy (CRRT) is complex, with the recommended maintenance doses being …
Prolonged administration of β-lactam antibiotics–a comprehensive review and critical appraisal
M Osthoff, M Siegemund, G Balestra, MH Abdul-Aziz… - Swiss medical …, 2016 - smw.ch
Prolonged infusion of β-lactam antibiotics as either extended (over at least 2 hours) or
continuous infusion is increasingly applied in intensive care units around the world in an …
continuous infusion is increasingly applied in intensive care units around the world in an …
Medication and fluid management of pediatric sepsis and septic shock
L Burgunder, C Heyrend, J Olson, C Stidham, RD Lane… - Pediatric Drugs, 2022 - Springer
Sepsis is a life-threatening response to infection that contributes significantly to neonatal
and pediatric morbidity and mortality worldwide. The key tenets of care include early …
and pediatric morbidity and mortality worldwide. The key tenets of care include early …
Surviving sepsis campaign: Research opportunities for infection and blood purification therapies
I Martin-Loeches, ME Nunnally, J Hellman… - Critical Care …, 2021 - journals.lww.com
OBJECTIVES: Patients with infection can develop sepsis, and their mortality can be high. An
important aspect in the treatment of sepsis is adequate management of the infection. DATA …
important aspect in the treatment of sepsis is adequate management of the infection. DATA …
Clinical outcomes of empirical high-dose meropenem in critically ill patients with sepsis and septic shock: a randomized controlled trial
T Lertwattanachai, P Montakantikul… - Journal of Intensive …, 2020 - Springer
Background Appropriate antimicrobial dosing is challenging because of changes in
pharmacokinetics (PK) parameters and an increase in multidrug-resistant (MDR) organisms …
pharmacokinetics (PK) parameters and an increase in multidrug-resistant (MDR) organisms …
Population pharmacokinetics and pharmacodynamics of meropenem in critically ill pediatric patients
J Saito, K Shoji, Y Oho, H Kato… - Antimicrobial Agents …, 2021 - Am Soc Microbiol
This study investigates the optimal meropenem (MEM) dosing regimen for critically ill
pediatric patients, for which there is a lack of pharmacokinetic (PK) studies. We conducted a …
pediatric patients, for which there is a lack of pharmacokinetic (PK) studies. We conducted a …
Pharmacokinetic/pharmacodynamic considerations of beta-lactam antibiotics in adult critically ill patients
AM Masich, MS Heavner, JP Gonzales… - … infectious disease reports, 2018 - Springer
Abstract Purpose of Review Beta-lactam antibiotics are commonly prescribed in critically ill
patients for a variety of infectious conditions. Our understanding of how critical illness alters …
patients for a variety of infectious conditions. Our understanding of how critical illness alters …
[HTML][HTML] Population pharmacokinetics of piperacillin in plasma and subcutaneous tissue in patients on continuous renal replacement therapy
M Bue, T Sou, ASL Okkels, P Hanberg… - International Journal of …, 2020 - Elsevier
Objectives Piperacillin is a β-lactam antimicrobial frequently used in critically ill patients with
acute kidney injury treated with continuous renal replacement therapy (CRRT). However …
acute kidney injury treated with continuous renal replacement therapy (CRRT). However …